Kaur R, Gulati M, Singh SK. Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. Int J Biol Macromol. 2016;11:1–42.

CAS  Google Scholar 

Izzo R, Bevivino G, Monteleone G, Izzo R, Bevivino G, Monteleone G. Tofacitinib for the treatment of ulcerative colitis. Expert Opin Investig Drugs. 2016:1–21.

Centre N. Clinical guideline. Ulcerative colitis : Management in adults, children and young people. In: Clinical guideline: methods, evidence and recommendations. London: National institute for health and care excellence (NICE); 2013. p. 1–297.

Google Scholar 

César B, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014;20(28):9458–67.

Google Scholar 

Baumgart DC. In: Colitis UD c. B, editor. Crohn’s disease and ulcerative colitis; from epidemiology and immunobiology to a rational diagnostic and therapeutic approach. Berlin: Springer Netherlands; 2012. p. 1–741.

Google Scholar 

Peirce CB, Kalady MF. Ulcerative proctitis and anorectal Crohn’s disease. Fundam Anorectal Surg. 2019;29:531–54.

Google Scholar 

Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Disease-a-Month. 2019;11:1–37.

Google Scholar 

Kameyama H, Nagahashi M, Shimada Y, Tajima Y, Ichikawa H. Genomic characterization of colitis- associated colorectal cancer. World J Surg Oncol. 2018;16:1–6.

Google Scholar 

Chandy G, Kurian G, Kurian S, Mathan M, Mathan VI, Patra S, et al. Risk of colorectal cancer in ulcerative colitis in India. J Gastroenterol Hepatol. 2005;20:705–9.

PubMed  Google Scholar 

Lakatos PL, Lakatos L. Ulcerative proctitis: a review of pharmacotherapy. Expert Opin Pharmacother. 2008;9:741–50.

CAS  PubMed  Google Scholar 

Morgado GC, Mancilla GP. Ulcerative proctitis. In: Ulcerative colitis – epidemiology, pathogenesis and complications. London: IntechOpen; 2011. p. 197–206.

Google Scholar 

Regueiro M, Loftus EV, Steinhart AH, Cohen RD. Clinical guidelines for the medical management of summary statement. Inflamm Bowel Dis. 2006;12:972–8.

PubMed  Google Scholar 

Bokemeyer B, Hommes D, Gill I, Broberg P, Dignass A. Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. J Crohn's Colitis. 2012;6:476–82.

Google Scholar 

Ghosh S, Shand A, Ferguson A. Clinical review - regular review ulcerative colitis. Br Med J. 2000;320:1119–23.

CAS  Google Scholar 

Bjerrum JT, Nielsen OH, Pittet V, Mueller C, Rogler G, Olsen J. Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia. Inflamm Bowel Dis. 2014;20:2340–52.

PubMed  Google Scholar 

Bürger M, Schmidt C, Teich N, Stallmach A. Medical therapy of active ulcerative colitis. Visz Gastrointest Med Surg. 2015;31:236–45.

Google Scholar 

Nasseri-moghaddam S. Inflammatory bowel disease. Middle east J Dig Dis. 2012;4:77–89.

PubMed  PubMed Central  Google Scholar 

Freeman HJ. Inflammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis. Can J Gastroenterol Hepatol. 1998;12:279–83.

CAS  Google Scholar 

Koutroubakis IE. Recent advances in the management of distal ulcerative colitis. World J Gastrointest Pharmacol Ther. 2010;1:43–50.

PubMed  PubMed Central  Google Scholar 

Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. J Autoimmun. 2014;13:49–52.

Google Scholar 

Kuester D, Dalicho S, Mo K, Benedix F, Lippert H, Guenther T, et al. Synchronous multifocal colorectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis. Pathol Res Pract. 2008;204:905–10.

PubMed  Google Scholar 

Teixeira FV, Hosne RS, Sobrado CW. Coloproctology systematic review of management of ulcerative colitis: a clinical update. J Coloproctol. 2015:1–8.

Pastorelli L, Pizarro TT, Cominelli F, Disease L, Unit GE, Milanese SD. Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs. 2015;14:505–21.

Google Scholar 

Arora S, Malik TA. Inflammatory bowel disease: epidemiology. In: New insights into inflammatory bowel disease. London: IntechOpen; 2016. p. 1–20.

Google Scholar 

Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohn's Colitis. 2014;8:288–95.

Google Scholar 

Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:503–7.

PubMed  Google Scholar 

Kaplan GG. IBD: global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2014;12:708–9.

Google Scholar 

Roberts-Thomson IC, Bryant RV, Costello SP. Uncovering the cause of ulcerative colitis. J Gastroenterol Hepatol. 2019;3:274–6.

Google Scholar 

Molodecky NA. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010;6:339–46.

Google Scholar 

Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors in inflammatory bowel diseases: evidence based environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016;22:6296–317.

CAS  PubMed  PubMed Central  Google Scholar 

Owczarek D, Rodacki T, Domagała-rodacka R, Cibor D, Mach T, Owczarek D, et al. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol. 2016;22:895–905.

CAS  PubMed  PubMed Central  Google Scholar 

Monif GR. Is ulcerative colitis a disease of a dysfunctional microbiota? Med Hypotheses. 2019;131:109300–2.

PubMed  Google Scholar 

Massimo Campieri PG. Bacteria as a cause of ulcerative colitis. Gut J. 2001;48:132–5.

Google Scholar 

Hawrelak JA, Hons B, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev. 2004;9:180–97.

PubMed  Google Scholar 

Loftus WV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.

PubMed  Google Scholar 

Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J. The risk of developing Crohn’s disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut J. 2007;56:1387–92.

Google Scholar 

Gl R, Je E, Dm P, Pandeya N, Hospital RB. A role for the appendix in inflammatory bowel disease? Gastroenterology. 2002;125:1270–2.

Google Scholar 

Zuo T, Kamm MA, Colombel J-F, Ng SC. Urbanization and the gut microbiota in health and inflammatory bowel disease. Gastroenterol Hepatol. 2018;7:440–52.

Google Scholar 

Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis. 2002;8:277–86.

PubMed  Google Scholar 

Hart AL, Hendy P. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre. Proc Nutr Soc. 2014;73:452–6.

CAS  PubMed  Google Scholar 

Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut. 2013;62:1505–10.

CAS  PubMed  Google Scholar 

Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, et al. A single species of Clostridium subcluster XIVa decreased in ulcerative colitis patients. Inflamm Bowel Dis. 2016;22:2802–10.

PubMed  Google Scholar 

Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2009;28:623–67.

Google Scholar 

Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, et al. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J Gastroenterol. 2017;23:45–8.

Google Scholar 

Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–83.

CAS  PubMed  Google Scholar 

Somineni HK, Kugathasan S. The microbiome in patients with inflammatory diseases. Clin Gastroenterol Hepatol. 2019;17(2):243–55.

PubMed  Google Scholar 

Pierce ES. Ulcerative colitis and Crohn’s disease: is Mycobacterium avium subspecies paratuberculosis the common villain? Gut Pathog. 2010;2:1–11.

Google Scholar 

Becker C, Neurath MF, Wirtz S. The intestinal microbiota in inflammatory bowel disease. ILAR J. 2015;56:192–204.

CAS  PubMed  Google Scholar 

Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, DeVinney R, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17:1971–8.

PubMed  Google Scholar 

Atarashi K, Suda W, Luo C, Kawaguchi T, Motoo I, Narushima S, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017;358:359–65.

CAS  PubMed  PubMed Central  Google Scholar 

Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9:1–12.

Google Scholar 

Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017;550:61–6.

CAS  PubMed  PubMed Central  Google Scholar 

Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, et al. Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course. Cell Host Microbe. 2018;24:600–10.

CAS  PubMed  PubMed Central  Google Scholar 

Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102–9.

PubMed  Google Scholar 

Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389:1218–28.

PubMed  Google Scholar 

Smits LP, Bouter KEC, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946–53.

PubMed  Google Scholar 

Yang YX, Chen X, Gan HT. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system: why were TLR3’s roles not tested? Gastroenterology. 2014;146:1428.

CAS  PubMed